The European Commission has published the final text of the Artificial Intelligence Act (AIA) which establishes a legal framework for “human centric and trustworthy” AI for medical devices, in vitro diagnostic devices (IVDs) and other products. The Act also sets harmonized rules for placing such products on the Community market. The AIA was published in…
Regulation (EU) 2024/1860 includes changes to the device regulations in the areas of Eudamed roll-out, interruption of device supply, and transitional provisions for certain IVDs. The regulation (and it’s almost immediate corrigendum) were mentioned in a press release from the Council of the European Union published on 30 May 2024, which identified that the regulation…
The US Food and Drug Administration (FDA) has proposed a draft guidance that would give medical device manufacturers more leeway in responding to misinformation about their products. The guidance comes as the agency has spent the past few years trying to dispel COVID-era misinformation that may have caused thousands of deaths. On 8 July 2024,…
The following new guidance documents for device manufacturers placing devices on the European market have been published in recent weeks: MDCG 2024-1-5: Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence MDCG 2022-13 Rev.1: Designation, re-assessment and notification of conformity assessment bodies and notified bodies MDCG 2024-10: Clinical evaluation of…
The US Food and Drug Administration (FDA) has recommended steps for drugmakers and medical device makers to improve racial, ethnic and other diversity in their clinical trials. The draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” includes suggestions for companies and researchers conducting trials on how to…
At the behest of Dr Peter Liese, MEP, who was co-rapporteur for the Medical Device Regulation (MDR, 2017/745), the European Parliament has provided the European Commission with a blueprint for an MDR Amending Regulation which would bring about significant changes to the current legislation. The 40-page document apparently addresses six principal concerns, with proposals for…
On 21 June 2024, the Council of the European Union adopted its conclusions on the Future of the European Health Union, emphasising critical areas such as availability of medical technologies, digitalisation of health, and building more resilient health systems. In a press release issued the same day, MedTech Europe called on Member States to enact…
Over the last few months the following new notified body designations have been announced: MDR – AFNOR Certification, France MDR – MTIC InterCert, Italy MDR – Kiwa Belgelendirme Hizmetleri, Turkey There are now 48 notified bodies designated under the MDR and 12 under the IVDR. A full list of notified bodies designated under the device…
The UK Medicines and Health products Regulatory Agency (MHRA) has today published its ‘Statement of policy intent: international recognition of medical devices’. This policy is intended to allow medical device manufacturers to use device clearances in other regulatory jurisdictions to ease entry to the GB (England, Scotland, Wales) market by recognising other international regulators’ approvals…
The Medicines and Healthcare products Regulatory Agency (MHRA) has set out its strategic approach to artificial intelligence (AI) in a new publication, available from here. Following publication of the UK Government’s white paper ‘A pro-innovation approach to AI regulation’, in 2023, the MHRA reports it has “taken significant steps in the past 12 months to…
